[Cardiovascular risks of non-steroidal anti-inflammatory drugs treatment]

Ugeskr Laeger. 2016 Dec 26;178(52):V08160612.
[Article in Danish]

Abstract

Non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used drugs. Current evidence supports that all NSAIDs increase the risk of heart failure and elevate blood pressure, whereas the risk of thrombotic events varies with the type of drug. Use of newer selective cyclooxygenase-2 inhibitors has been associated with a substantial vascular risk but increasing concern also relates to traditional NSAIDs, in particular diclofenac. This review summarizes the current evidence regarding the cardiovascular safety of NSAIDs and presents recommendations for their use.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Atrial Fibrillation / chemically induced
  • Blood Pressure / drug effects
  • Cardiovascular Diseases / chemically induced*
  • Cyclooxygenase 2 Inhibitors / adverse effects
  • Diclofenac / adverse effects
  • Drug Prescriptions / statistics & numerical data
  • Heart Failure / chemically induced
  • Humans
  • Myocardial Ischemia / chemically induced
  • Risk Factors
  • Venous Thromboembolism / chemically induced

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Diclofenac